• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women suffering from ADHD must make a difficult decision about whether to continue or stop taking ADHD medication during pregnancy and breast-feeding. There are few data regarding how exposure over time may affect the pregnant fetus.

A study recently published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological problems such as hearing loss or vision, febrile seizures, or IQ impairment. The authors acknowledge the need for more high-quality studies.

Risk/Benefit Analysis

Women who are expecting and taking ADHD medication must weigh the benefits of taking it against the possible risks to the baby. Doctors don't have the data needed to make unequivocal recommendations but they can provide information about risks and benefits that assist pregnant women in making informed choices.

A study published in Molecular Psychiatry found that women who took ADHD medications during early pregnancy did not have a significantly increased risk of fetal cardiac malformations or major birth defects that are structural. Researchers conducted a massive population-based study of case control to examine the prevalence of structural defects that were major in infants born to mothers who used stimulants during pregnancy. Clinical geneticists, pediatric cardiologists and other experts examined the cases to ensure that the classification was correct and to eliminate any bias.

The research conducted by the researchers was not without limitations. The researchers were not able, in the first place, to separate the effects of the medication from the disorder. That limitation makes it difficult to determine whether the limited associations observed in the exposed groups are due to the use of medication or comorbidities that cause confusion. The researchers also did not examine the long-term effects for the offspring.

The study found that babies whose mothers had taken ADHD medication during pregnancy had a greater risk of being admitted to the neonatal care unit (NICU), compared to mothers who didn't take any medication during pregnancy, or had stopped taking their medication before or during pregnancy. The reason for this was central nervous system disorders, and the increased risk of admission was not found to be affected by the type of stimulant medication was used during pregnancy.

Women who took stimulant ADHD medication during pregnancy also had an elevated chance of having a caesarean section or having a baby with low Apgar score (less than 7). These increases appear to be independent of the type of medication taken during pregnancy.

Researchers suggest that the minor risks posed by the use of ADHD medications during early pregnancies may be offset by the greater benefits for mother and baby of continuing treatment for the woman's condition. Physicians should discuss the issue with their patients and, where possible, assist them in developing strategies to improve their coping abilities which can reduce the impact of her disorder on her daily life and relationships.

Interactions with Medication

As more women than ever are diagnosed with ADHD and treated with medication, the question of whether or not to discontinue treatment during pregnancy is one that more and more physicians have to face. The majority of these decisions are taken in the absence of solid and reliable evidence in either case, which means that doctors must weigh what they know about their experiences, the experiences of other doctors, and what research says on the topic and their own best medication for adhd combined type judgment for each patient.

In particular, the issue of potential risks for the infant can you get adhd medication without a diagnosis be difficult. The research on this subject is based on observations rather than controlled studies and a lot of the results are in conflict. Most studies focus on live-births, which could underestimate the teratogenic impact leading to abortions or terminations of pregnancy. The study presented in the journal club addresses these shortcomings by analyzing both the data from deceased and live births.

The conclusion The conclusion: While some studies have shown a positive association between ADHD medications and the possibility of certain birth defects, other studies have not found any evidence of a link, and most studies show a neutral or even slightly negative effect. Therefore, a careful risk/benefit assessment must be conducted in every case.

For women suffering from ADHD and ADD, the decision to stop medication is difficult, if not impossible. In a recent article in Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can increase depression, feelings of loneliness, and family conflict for patients with ADHD. Furthermore, a loss of medication may affect the ability to do job-related tasks and drive safely which are essential aspects of daily life for many people with ADHD.

She suggests that women who are not sure whether to continue taking medication or discontinue it due to pregnancy, educate their family members, coworkers and their friends about the condition, the impact on daily functioning and the benefits of keeping the current treatment regimen. It can also help a woman feel confident about her decision. Some medications can pass through the placenta. If the patient decides not to take her ADHD medication while pregnant and breastfeeding, it's important to be aware that the medication may be transferred to her infant.

Birth Defects and Risk of

As the use of ADHD medications to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases, so do concerns about the effects that the drugs might have on the fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge regarding this topic. Researchers utilized two massive datasets to analyze over 4.3 million pregnancy and determine if the use of stimulant medications caused birth defects. Researchers discovered that, while the overall risk is low, the first trimester ADHD medication exposure was associated with slightly higher risk of specific heart defects like ventriculoseptal defect.

The researchers of the study could not find any association between early use of medication and other congenital anomalies such as facial deformities or club feet. The results are in line with previous studies that showed a small, but significant increase in cardiac malformations for women who began taking ADHD medication prior to the time of pregnancy. The risk increased in the latter half of pregnancy, when a lot of women stopped taking their medication.

Women who took ADHD medications in the first trimester of their pregnancies were also more likely to undergo caesarean sections, a low Apgar score after delivery and a baby that required breathing assistance at birth. The authors of the study could not eliminate bias due to selection because they limited their study to women with no other medical conditions that might have contributed to the findings.

Researchers hope their research will provide doctors with information when they encounter pregnant women. The researchers recommend that while discussing benefits and risks are important, the choice about whether to continue or stop medication should be made in light of the severity of each woman's ADHD symptoms and the needs of the woman.

The authors also caution that even though stopping the medication is an alternative, it is not an option to consider due to the high prevalence of depression and other mental health problems for women who are expecting or recently post-partum. Further, the research suggests that women who choose to stop taking their medication are more likely to experience difficulties adjusting to life without them following the birth of their baby.

Nursing

The responsibilities of being a new mother can be overwhelming. Women who suffer from ADHD who have to deal with their symptoms while attending doctor appointments, preparing for the arrival of a child and getting used to new adhd medication uk routines at home may face a lot of challenges. Many women decide to continue taking their ADHD medication during pregnancy.

The majority of stimulant medications are absorbed by breast milk in very small quantities, so the risk to the nursing infant is very low. The rate of exposure to medication will differ based on dosage, frequency of administration and the time of the day. Additionally, different medications enter the baby's system differently through the gastrointestinal tract and breast milk and the impact of this on a newborn is not well understood.

Due to the absence of research, some doctors may be inclined to discontinue stimulant drugs during a woman's pregnancy. It's a difficult choice for the woman, who must weigh the advantages of her medication against the potential risks to the fetus. As long as there is no more information, doctors should inquire with all pregnant patients about their history of Adhd medication Uk buy and if they plan or are taking to take medication during the perinatal period.

Numerous studies have demonstrated that women can continue to take their ADHD medication safely during pregnancy and breast-feeding. In response, an increasing number of patients are opting to do this. They have found after consulting with their doctors that the benefits of continuing their current medication outweigh potential risks.

Women with ADHD who plan to breastfeed should seek advice from a specialist psychiatrist prior to becoming pregnant. They should discuss their medication with their doctor and discuss the advantages and disadvantages of continued treatment, including non-pharmacological management strategies. Psychoeducation is also needed to help pregnant women suffering from ADHD be aware of the symptoms and underlying disorder. They should also be educated about treatment options and strengthen coping mechanisms. This should be a multidisciplinary effort including obstetricians, GPs, and psychiatry. Pregnancy counseling should include discussion of a treatment plan for the mother and child, monitoring of signs of deterioration, and, if needed, adjustments to the medication regimen.